Spire Healthcare Group PLC (LON:SPI) insider Justin Ash purchased 89,100 shares of the company’s stock in a transaction on Friday, September 29th. The stock was acquired at an average cost of GBX 224 ($3.01) per share, for a total transaction of £199,584 ($268,402.37).

Shares of Spire Healthcare Group PLC (SPI) traded up 0.36% during trading on Monday, hitting GBX 225.70. The stock had a trading volume of 803,684 shares. The firm’s market cap is GBX 904.02 million. The stock has a 50 day moving average of GBX 322.20 and a 200 day moving average of GBX 331.83. Spire Healthcare Group PLC has a 52-week low of GBX 220.30 and a 52-week high of GBX 405.70.

Spire Healthcare Group PLC (LON:SPI) last released its quarterly earnings data on Thursday, September 14th. The company reported GBX 8.70 ($0.12) EPS for the quarter, beating the consensus estimate of GBX 8.60 ($0.12) by GBX 0.10 ($0.00). Spire Healthcare Group PLC had a return on equity of 1.71% and a net margin of 1.85%. The company had revenue of £481 million for the quarter. On average, equities analysts anticipate that Spire Healthcare Group PLC will post $18.48 EPS for the current year.

The business also recently announced a dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Thursday, November 16th will be paid a dividend of GBX 1.30 ($0.02) per share. This represents a yield of 0.5%. The ex-dividend date of this dividend is Thursday, November 16th.

ILLEGAL ACTIVITY WARNING: This article was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://www.watchlistnews.com/spire-healthcare-group-plc-spi-insider-buys-199584-in-stock/1603108.html.

Several analysts have recently weighed in on SPI shares. J P Morgan Chase & Co lowered their price objective on shares of Spire Healthcare Group PLC from GBX 376 ($5.06) to GBX 339 ($4.56) and set a “neutral” rating for the company in a research note on Friday, September 15th. Liberum Capital reiterated a “hold” rating and set a GBX 350 ($4.71) price objective on shares of Spire Healthcare Group PLC in a report on Thursday, September 14th. Credit Suisse Group reaffirmed an “underperform” rating on shares of Spire Healthcare Group PLC in a research report on Friday, July 21st. Berenberg Bank lifted their price target on Spire Healthcare Group PLC from GBX 360 ($4.84) to GBX 390 ($5.24) and gave the company a “buy” rating in a research note on Wednesday, June 21st. Finally, Numis Securities Ltd reissued an “add” rating and issued a GBX 350 ($4.71) price objective on shares of Spire Healthcare Group PLC in a research note on Thursday, September 14th. One research analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. The company has an average rating of “Hold” and a consensus target price of GBX 316.86 ($4.26).

About Spire Healthcare Group PLC

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.